Target intelligence / Profile preview

Phospholipid membranes of acidic intracellular organelles

Molecular classification
Lipid bilayer, Cellular membrane
01

Overview

Phospholipid membranes of acidic intracellular organelles, such as lysosomes and endosomes, are specialized lipid bilayers that maintain a highly acidic internal environment (pH 4.5–5.0) necessary for cellular homeostasis. These membranes are characterized by a unique lipid composition, including bis(monoacylglycero)phosphate (BMP), which supports the activity of acid hydrolases and facilitates membrane fusion events during autophagy and endocytosis [6, 14]. In pharmacology, these membranes act as a target for lysosomotropic agents, which are weakly basic, lipophilic molecules that accumulate within the acidic lumen via ion trapping [7, 10]. This accumulation can be leveraged therapeutically to neutralize organelle pH, inhibit viral entry, or trigger lysosomal membrane permeabilization (LMP) to induce apoptosis in cancer cells [8, 15]. However, chronic interaction with these membranes by cationic amphiphilic drugs can lead to drug-induced phospholipidosis, a condition where the accumulation of drug-lipid complexes interferes with normal lipid metabolism and leads to the formation of lamellar inclusion bodies [1, 4]. Understanding the biophysical properties of these membranes is essential for the development of pH-sensitive drug delivery systems and for managing the safety profiles of many common medications [17, 20].

Other names
Lysosomal membranesEndosomal membranesAcidic compartment membranesIntracellular acidic membranesEndolysosomal membranes
02

Mechanism of action

Lysosomotropism: Cationic amphiphilic drugs (CADs) accumulate in acidic compartments via ion trapping. Once inside, they can neutralize pH, inhibit acid hydrolases (such as acid sphingomyelinase), and induce lysosomal membrane permeabilization (LMP) to trigger apoptosis.

03

Biological functions

CompartmentalizationIntracellular digestionpH homeostasisAutophagyEndocytosisSignal transductionLipid metabolism
04

Disease associations

Lysosomal storage diseaseViral infectionParasitic infectionCancerNeurodegenerative diseaseDrug-induced phospholipidosis
05

Safety considerations

Drug-induced phospholipidosis (DIPL)RetinopathyQT interval prolongationLysosomal dysfunctionCytoplasmic vacuolization
06

Interacting drugs

Chloroquine

9 more in the full profile.

07

Biomarkers

Di-22:6-bis(monoacylglycerol)phosphate (BMP/LBPA)Lysosomal pHCathepsin D releaseLAMP-1 expressionMyeloid bodies (via transmission electron microscopy)

Beyond the preview

Go deeper on Phospholipid membranes of acidic intracellular organelles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid membranes of acidic intracellular organelles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call